Stay updated on INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.

Latest updates to the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedThe site footer's revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check10 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, indicating a site software update.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study record’s revision history was updated to add revision v3.7.0 and remove v3.6.6, indicating a new posting to the record. This reflects an update to the record metadata rather than changes to the study content.SummaryDifference0.1%

- Check52 days agoChange DetectedThe record history now indicates a new software revision (v3.6.6) replacing the prior revision (v3.6.5), reflecting a behind-the-scenes release update rather than a change to study content.SummaryDifference0.1%

- Check73 days agoChange DetectedThe footer now shows the revised system version from v3.6.4 to v3.6.5, indicating a backend/UI update. This change does not modify the study history entries or any trial data displayed on the page.SummaryDifference0.1%

- Check88 days agoChange DetectedThe revision tag at the bottom of the page updated from v3.6.3 to v3.6.4. This indicates a behind-the-scenes update to the ClinicalTrials.gov interface on the study history page.SummaryDifference0.1%

Stay in the know with updates to INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INDUCE-3: GSK3359609 & Pembrolizumab Clinical Trial page.